Exact Sciences
EXAS
#1851
Rank
NZ$15.73 B
Marketcap
$84.69
Share price
0.30%
Change (1 day)
-12.68%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -NZ$1.79 Billion

According to Exact Sciences's latest financial reports the company's current earnings are NZ$2.75 Billion. a decrease over its 2023 earnings that were of -NZ$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$1.81 Billion435.08%
2023 -NZ$0.34 Billion-69.28%
2022 -NZ$1.11 Billion-25.55%
2021 -NZ$1.48 Billion1.68%
2020 -NZ$1.46 Billion271.17%
2019 -NZ$0.4 Billion58.99%
2018 -NZ$0.25 Billion20.89%
2017 -NZ$0.21 Billion-30.95%
2016 -NZ$0.3 Billion5.09%
2015 -NZ$0.29 Billion57.24%
2014 -NZ$0.18 Billion116.53%
2013 -NZ$82.46 Million
2011 -NZ$51.34 Million143.73%
2010 -NZ$21.07 Million27.85%
2009 -NZ$16.48 Million0.27%
2008 -NZ$16.43 Million-20.95%
2007 -NZ$20.79 Million-13.53%
2006 -NZ$24.04 Million-10.07%
2005 -NZ$26.73 Million-21.81%
2004 -NZ$34.19 Million-33.44%
2003 -NZ$51.37 Million-6.51%
2002 -NZ$54.94 Million17.95%
2001 -NZ$46.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.21 Billion-88.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.11 B-106.49%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$14.55 Million-99.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$62.28 Million-96.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$14.14 B-882.10%๐Ÿ‡ซ๐Ÿ‡ท France